Nigil Haroon

34PUBLICATIONS
75CO-AUTHORS
Rheumatology and arthritisAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)RehabilitationSolution chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 29, 2026
Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy.

|May 11, 2026
T cells, the Next Big Target in Axial Spondyloarthritis?

|Apr 27, 2026
Determinants of Difficult-to-Manage and Treatment-Refractory Axial Spondyloarthritis: A Cross-Sectional Analysis Within a Longitudinal Cohort.

|Apr 01, 2026
Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non-Biologic Treatment: Results From an Overlap Weighting Analysis in High-Risk Patients With Axial Spondyloarthritis.

Nigil Haroon, Zeynep Baskurt, Tina Chim

|Mar 16, 2026
Segmental spinal damage predicts mobility restriction and functional decline in radiographic axial spondyloarthritis: a longitudinal study.

Ismail Sari, Seunghun Lee, Sindhu R Johnson

|Aug 18, 2025
Inflammatory bowel disease does not confer higher disease activity or greater radiographic progression in axial spondyloarthritis.

Patricia Remalante-Rayco, Yassir Daghistani, Tina Chim

Pageof 6

Frequent Collaborators

12 joint publications

Robert Inman

6 joint publications

Laura Passalent

4 joint publications

Ismail Sari

4 joint publications

Sherry Rohekar